|
Platelet Aggregation
|
D010974 |
[The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS.
] |
|
Osmium
|
D009992 |
[A very hard, gray, toxic, and nearly infusible metal element, atomic number 76, atomic weight 190.2, symbol Os.
] |
|
Gestrinone
|
D04.210.500.668.651.568.620.400 |
|
|
Norgestrienone
|
D04.210.500.668.651.568.620 |
|
|
Platelet Aggregation Inhibitors
|
D010975 |
[Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
] |
|
Epstein-Barr Virus Nuclear Antigens
|
D019309 |
[Nuclear antigens encoded by VIRAL GENES found in HUMAN HERPESVIRUS 4. At least six nuclear antigens have been identified.
] |
|
Platelet Count
|
D010976 |
[The number of PLATELETS per unit volume in a sample of venous BLOOD.
] |
|
Oryzias
|
D009990 |
[Common name for a species in the genus Oryzias.
, Common name of the family Oryziinae, which only contains the one genus ORYZIAS.
, The only genus in the family Oryziinae, order BELONIFORMES. Oryzias are egg-layers; other fish of the same order are livebearers. Oryzias are used extensively in testing carcinogens.
] |
|
Platelet Factor 3
|
D010977 |
[A phospholipid from the platelet membrane that contributes to the blood clotting cascade by forming a phospholipid-protein complex (THROMBOPLASTIN) which serves as a cofactor with FACTOR VIIA to activate FACTOR X in the extrinsic pathway of BLOOD COAGULATION.
] |
|
Platelet Factor 4
|
D010978 |
[A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or a tetramer depending upon its concentration in solution. Platelet factor 4 has a high affinity for HEPARIN and is often found complexed with GLYCOPROTEINS such as PROTEIN C.
] |
|
Purinergic Agonists
|
D058913 |
[Compounds that bind to and activate PURINERGIC RECEPTORS.
] |
|
Epilepsy, Rolandic
|
D019305 |
[An autosomal dominant inherited partial epilepsy syndrome with onset between age 3 and 13 years. Seizures are characterized by PARESTHESIA and tonic or clonic activity of the lower face associated with drooling and DYSARTHRIA. In most cases, affected children are neurologically and developmentally normal. (From Epilepsia 1998 39;Suppl 4:S32-S41)
] |
|
Purinergic Antagonists
|
D058914 |
[Drugs that bind to and block the activation of PURINERGIC RECEPTORS.
] |
|
Artemisia
|
D019306 |
[A species of ARTEMISIA that contains judaicin (eudesmane type sesquiterpene lactone).
, A plant genus of the family ASTERACEAE with strong-smelling foliage. It is a source of SANTONIN and other cytotoxic TERPENES.
, The common name of wormwood or mugwort may refer to other species of ARTEMISIA. Source of allergen Ag7.
] |
|
Purinergic P1 Receptor Antagonists
|
D058915 |
[Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.
] |
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
|
D019307 |
[A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
] |
|
Valine Dehydrogenase (NADP+)
|
D08.811.682.664.500.924 |
|
|
Adenosine A1 Receptor Antagonists
|
D058916 |
[Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS.
] |
|
Palmitic Acid
|
D019308 |
[A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.
] |
|
Oleic Acid
|
D019301 |
[An unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (Stedman, 26th ed)
] |
